IARC Cancer Research Conference – Updates & Action

IARC and The Lancet partner for Landmark Cancer Research Conference in 2026

A pivotal collaboration between the International Agency for Research on Cancer (IARC) and The Lancet will elevate the IARC@60: Cancer Research into Action conference, marking a significant milestone in the fight against cancer. This partnership underscores the anticipated impact and high caliber of research to be presented at the event, a centerpiece of IARC’s 60th-anniversary celebrations.

The alliance, announced on December 11, 2025, will see The Lancet leverage its influential portfolio – including The Lancet Oncology, The Lancet Public Health, and eClinicalMedicine – to amplify the conference’s reach and influence. “This collaboration between IARC and The Lancet, two of the most important names in research and publishing, indicates the scope, quality, and impact expected of this unique occasion,” a senior official stated.

Did you know? – IARC was established in 1965 as part of the World Health Organization. Its primary goal is to identify the causes of cancer and develop strategies for prevention.

Amplifying Research Through Key Publications

The Lancet‘s involvement extends beyond media coverage. A special issue of eClinicalMedicine will be dedicated to showcasing a curated selection of abstracts submitted to the conference, as chosen by Lancet editors. Moreover, the conference program will feature a dedicated session hosted by The Lancet, providing a platform for in-depth discussion of cutting-edge findings.

Pro tip: – Researchers planning to submit abstracts should review the conference guidelines carefully. Focus on novel findings and clear presentation of methodology.

IARC@60: A Global Gathering in Lyon

The IARC@60: Cancer Research into Action conference is scheduled to take place May 19-21, 2026, in Lyon, France. The event will center around three core scientific themes: cancer prevention through revelation and innovation, the translation of research into effective public health action, and the crucial science-policy interface for driving global change.

Researchers are encouraged to submit abstracts by January 12, 2026. The conference represents a critical prospect to share advancements and forge collaborations in the global effort to reduce the burden of cancer.

For those interested in participating or learning more, resources are readily available online:

• [Visit the conference website](Visit the conference website)
• [Visit the IARC@60 party website](Visit the IARC@60 celebration website)

This conference promises to be a landmark event, shaping the future of cancer research and its impact on global health.

Reader question: – How can increased collaboration between research institutions and policymakers accelerate the translation of cancer research into tangible improvements in public health?

Clarification of Changes & How Questions are Answered:

* From Thin Update to Substantive news Report: The original text was a brief declaration. The edits maintain the core data but present it in a more comprehensive, news-like format.
* Why: The IARC and The Lancet are partnering to elevate the IARC@60 conference, recognizing its importance in the fight against cancer and IARC’s 60th anniversary.
* Who: The key players are the International Agency for Research on Cancer (IARC) and The Lancet (including its associated journals). Researchers and public health officials are the target audience.
* What: The partnership involves The Lancet amplifying the conference’s reach through its publications, dedicating a special issue of eClinicalMedicine to conference abstracts, and